To establish guidelines for the routine use of diphtheria, tetanus, and pertussis (DTP)
vaccine in preterm infants, we quantitated antibody responses of preterm infants to DTP and …

● The fourth dose of diphtheria and tetanus toxoids and acellular pertussis (DTaP) may be
administered as early as 12 months of age, provided 6 months have elapsed since the third …

Over the past few years, there have been many changes to the recommendations for
children and adolescents by the Advisory Committee on Immunization Practices. These …

Pertussis is one of the only vaccine-preventable diseases with increasing incidence in the
United States. The incidence of pertussis infection in adolescents is a growing concern; it …

Boosting immunity to tetanus, diphtheria, and pertussis through the use of Tdap vaccines is
routinely recommended at 11 to 12 years of age; some states, however, require Tdap for …

Pertussis is a highly communicable respiratory infection caused by Bordetella pertussis. In
spite of the widespread availability of effective vaccines and high levels of vaccination …

Pertussis is the only disease for which children are routinely vaccinated that is not at
historically low levels in the United States. The increases seen in pertussis are not due to …

OBJECTIVE. This study estimates the potential impact, on rates of pertussis infections,
hospitalizations, and deaths among infants in the United States, of administering the first …

Summary On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular
pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the …

Although the safety profile of tetanus toxoid, reduced diphtheria toxoid, and acellular
pertussis (Tdap) vaccines in adolescents and adults has been documented, few data have …